세계의 프로게스테론 시장 보고서(2025년)

Progesterone is a steroid hormone that plays a key role in regulating the menstrual cycle, supporting pregnancy, and contributing to embryonic development in humans and other animals. It helps prepare the endometrial lining of the uterus for the implantation of a fertilized egg, supports early stages of pregnancy, and prevents additional ovulation during pregnancy. Additionally, progesterone is utilized in hormone replacement therapy and in contraceptive pills, where it is used in synthetic forms known as progestins.

The primary types of progesterone products include natural and synthetic progesterone. Natural progesterone, also known as bioidentical progesterone, is typically extracted from plant sources such as soybeans and wild yams. These products are available in both generic and branded options and can be delivered through various methods, including oral, injectable, transdermal, and others. Progesterone is used in a wide range of applications, including treatment for menopause, birth control, abnormal uterine bleeding, hyperplastic precursor lesions, and endometrial cancer. Key end-users include hospitals, clinics, research institutions, and other medical facilities.

The progesterone market research report is one of a series of new reports from The Business Research Company that provides progesterone market statistics, including progesterone industry global market size, regional shares, competitors with an progesterone market share, detailed progesterone market segments, market trends and opportunities, and any further data you may need to thrive in the progesterone industry. The progesterone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The progesterone market size has grown rapidly in recent years. It will grow from $1.56 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. Factors contributing to this historic growth include a surge in infertility cases, increasing reliance on assisted reproductive technologies, a rise in menstrual disorders, heightened awareness of women's health, and growing demand for bioidentical hormone treatments.

The progesterone market size is expected to see rapid growth in the next few years. It will grow to $3.09 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. This projected growth is driven by a rising population of aging women, higher rates of hormonal imbalance conditions, increased preference for injectable and transdermal drug delivery options, greater emphasis on preventive health measures, and expanding healthcare expenditures. Key trends expected during the forecast period include innovations in transdermal drug delivery, creation of long-acting formulations, progress in the customization of bioidentical hormones, enhanced oral absorption methods, and the development of intelligent drug delivery patch systems.

The growing prevalence of hormonal disorders is anticipated to drive the expansion of the progesterone market in the coming years. Hormonal disorders are medical conditions that result from imbalances or malfunctions within the endocrine system, which is responsible for producing and regulating hormones that influence essential bodily functions such as metabolism, reproduction, growth, and mood. The rise in hormonal disorders can be attributed to modern lifestyle factors, including unhealthy diets, chronic stress, physical inactivity, and increased exposure to environmental toxins. Progesterone plays a key role in managing these disorders by helping to restore hormonal balance, regulate menstrual cycles, and alleviate symptoms associated with estrogen dominance. Additionally, it supports the function of other hormones like estrogen and cortisol, thereby contributing to the stabilization of the endocrine system and addressing conditions such as polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS). For example, in January 2025, the World Health Organization reported that PCOS is a significant public health concern and one of the most common hormonal disorders among women of reproductive age, affecting an estimated 6-13% annually. As a result, the increasing incidence of hormonal disorders is fueling the growth of the progesterone market.

Key players in the progesterone market are investing in innovative drug formulations, such as soft vaginal capsules, to enhance patient compliance and improve drug absorption. Soft vaginal capsules are smooth, gel-like inserts intended for vaginal administration, enabling localized drug delivery to address infections, promote hormonal balance, and support overall vaginal health. In April 2024, Besins Healthcare (UK) Limited, a pharmaceutical manufacturing company based in the UK, introduced Prometrium 400mg soft vaginal capsules aimed at preventing miscarriage in women experiencing early pregnancy bleeding and with a history of recurrent miscarriage. This novel product, the first of its kind licensed in the UK, offers a non-invasive and targeted delivery method that enhances progesterone absorption at the site of action, leading to improved therapeutic outcomes and greater patient adherence.

In October 2024, Audax Private Equity, a US-based investment firm, acquired the clinical services division of Avantor, Inc. for an undisclosed sum. With this acquisition, Audax launched Resonant Clinical Solutions, an independent platform within the outsourced clinical trial services industry. The move is intended to expand service offerings and capitalize on long-standing relationships with clients. Avantor, Inc., the former owner of the division, is a biotechnology company based in the US that supplies progesterone.

Major players in the progesterone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Allergan plc, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Gedeon Richter Plc., Dr. Reddy's Laboratories Ltd., Cipla Limited, Cadila Pharmaceuticals Ltd., Aspen Pharmacare, BIOCON Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Beximco Pharmaceuticals Ltd., Besins healthcare (UK) limited., Sichuan Deebio Pharmaceutical Co. Ltd., Changzhou Siyao Pharmaceuticals Co. Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd.

North America was the largest region in the progesterone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in progesterone report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the progesterone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The progesterone market consists of sales of oral capsules, vaginal gels, creams, injections, and intrauterine devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Progesterone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on progesterone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for progesterone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The progesterone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Natural Progesterone; Synthetic Progesterone
• 2) By Drug Type: Branded; Generic
• 3) By Route Of Administration: Injectable; Oral; Transdermal; Other Routes Of Administration
• 4) By Application: Menopause; Contraception; Dysfunctional Uterine Bleeding; Hyperplastic Precursor Lesions; Endometrial Cancer; Other Applications
• 5) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
• Subsegments:
• 1) By Natural Progesterone: Oral Capsules; Vaginal Gels; Creams; Injections; Suppositories
• 2) By Synthetic Progesterone: Progestins; Oral Contraceptives; Hormone Replacement Therapy (HRT) Formulations; Injectable Contraceptives; Intrauterine Devices
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co Inc.; Allergan plc; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Progesterone Market Characteristics

3. Progesterone Market Trends And Strategies

4. Progesterone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Progesterone Growth Analysis And Strategic Analysis Framework

• 5.1. Global Progesterone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Progesterone Market Growth Rate Analysis
• 5.4. Global Progesterone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Progesterone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Progesterone Total Addressable Market (TAM)

6. Progesterone Market Segmentation

• 6.1. Global Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Progesterone
• Synthetic Progesterone
• 6.2. Global Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Branded
• Generic
• 6.3. Global Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Transdermal
• Other Routes Of Administration
• 6.4. Global Progesterone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Menopause
• Contraception
• Dysfunctional Uterine Bleeding
• Hyperplastic Precursor Lesions
• Endometrial Cancer
• Other Applications
• 6.5. Global Progesterone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Institutes
• Other End-Users
• 6.6. Global Progesterone Market, Sub-Segmentation Of Natural Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral capsules
• Vaginal gels
• Creams
• Injections
• Suppositories
• 6.7. Global Progesterone Market, Sub-Segmentation Of Synthetic Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Progestins
• Oral Contraceptives
• Hormone Replacement Therapy (HRT) Formulations
• Injectable Contraceptives
• Intrauterine Devices

7. Progesterone Market Regional And Country Analysis

• 7.1. Global Progesterone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Progesterone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Progesterone Market

• 8.1. Asia-Pacific Progesterone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Progesterone Market

• 9.1. China Progesterone Market Overview
• 9.2. China Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Progesterone Market

• 10.1. India Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Progesterone Market

• 11.1. Japan Progesterone Market Overview
• 11.2. Japan Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Progesterone Market

• 12.1. Australia Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Progesterone Market

• 13.1. Indonesia Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Progesterone Market

• 14.1. South Korea Progesterone Market Overview
• 14.2. South Korea Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Progesterone Market

• 15.1. Western Europe Progesterone Market Overview
• 15.2. Western Europe Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Progesterone Market

• 16.1. UK Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Progesterone Market

• 17.1. Germany Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Progesterone Market

• 18.1. France Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Progesterone Market

• 19.1. Italy Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Progesterone Market

• 20.1. Spain Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Progesterone Market

• 21.1. Eastern Europe Progesterone Market Overview
• 21.2. Eastern Europe Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Progesterone Market

• 22.1. Russia Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Progesterone Market

• 23.1. North America Progesterone Market Overview
• 23.2. North America Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Progesterone Market

• 24.1. USA Progesterone Market Overview
• 24.2. USA Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Progesterone Market

• 25.1. Canada Progesterone Market Overview
• 25.2. Canada Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Progesterone Market

• 26.1. South America Progesterone Market Overview
• 26.2. South America Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Progesterone Market

• 27.1. Brazil Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Progesterone Market

• 28.1. Middle East Progesterone Market Overview
• 28.2. Middle East Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Progesterone Market

• 29.1. Africa Progesterone Market Overview
• 29.2. Africa Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Progesterone Market Competitive Landscape And Company Profiles

• 30.1. Progesterone Market Competitive Landscape
• 30.2. Progesterone Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Allergan plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Progesterone Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Sun Pharmaceutical Industries Ltd
• 31.4. Gedeon Richter Plc.
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Cipla Limited
• 31.7. Cadila Pharmaceuticals Ltd.
• 31.8. Aspen Pharmacare
• 31.9. BIOCON Ltd.
• 31.10. Zhejiang Xianju Pharmaceutical Co. Ltd.
• 31.11. Beximco Pharmaceuticals Ltd.
• 31.12. Besins healthcare (UK) limited.
• 31.13. Sichuan Deebio Pharmaceutical Co. Ltd.
• 31.14. Changzhou Siyao Pharmaceuticals Co. Ltd.
• 31.15. Shanghai Shyndec Pharmaceutical Co. Ltd.

32. Global Progesterone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Progesterone Market

34. Recent Developments In The Progesterone Market

35. Progesterone Market High Potential Countries, Segments and Strategies

• 35.1 Progesterone Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Progesterone Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Progesterone Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer